Chronic myelogenous leukemia
in the lymphoid blastic phase: characteristics, treatment response, and prognosis.
Tyrosine Kinase Inhibitors of Bcr-Abl in Chronic Myelogenous Leukemia
Characteristic Imatinib Targets Bcr-Abl tyrosine kinases Response rates Complete cytogenetic response occurred in more than 80% of patients in early chronic phase; in accelerated and blast phases, 76% and 34% had hematologic remissions.
Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Chronic Myelogenous Leukemia
(CML) Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.
Histologic examination of a subsequent bone marrow biopsy confirmed that the patient had also experienced a relapse of his chronic myelogenous leukemia
bcr-abl RNA in patients with chronic myelogenous leukemia
Bafetinib has shown significant activity in blocking B-CLL proliferation in vitro and anti-tumor activity in patients with chronic myelogenous leukemia
, who have failed first- and second-line therapy.
Being alert to the potential development of such problems in patients with underlying myeloproliferative diseases such as chronic myelogenous leukemia
or myelofibrosis might prevent unnecessary surgery.
The medicine known commercially as Gleevec serves as a powerful weapon for people fighting the blood cancer called chronic myelogenous leukemia
, or CML.
He was diagnosed with chronic myelogenous leukemia
in April and went to UCLA for treatment.
com/research/f4ffea/acute_lymphoblasti) has announced the addition of the "Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia
or Acute Myelogenous Leukemia or Hairy Cell Leukemia Therapy Area Pipeline Report" report to their offering.
VAL-083 therapeutic activity seen in glioblastoma, chronic myelogenous leukemia
and non-small cell lung cancer
4, 5) A well-documented association has been found between juvenile xanthogranuloma and childhood leukemia, most often juvenile chronic myelogenous leukemia
The early stage of chronic myelogenous leukemia
(CML), a form of the disease accounting for 15 percent of adult cases, is fairly mild, says Vigneri.
It will take about eight weeks to find out if any of the volunteers who gave blood samples Saturday are a match for Piya, who was diagnosed with chronic myelogenous leukemia
in October 1998.
Administration of the PR1 vaccine to some patients elicits the proliferation of, PR1-specific cytotoxic T lymphocytes that selectively kill three types of leukemia - myelodysplastic syndrome, acute myelogenous leukemia and chronic myelogenous leukemia